ROBERT L. BARBIERI, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The recent review of danazol by Madanes and Farber (1) is an excellent summary of the drug's properties. However, there are a few substantive errors that need correction.
Madanes and Farber state than danazol inhibits adrenal 16α-hydroxylase. The paper (2) they cite to support this statement does not examine the effects of danazol on 16α-hydroxylase, and other unpublished reports have shown that danazol does not inhibit 16α-hydyroxylase. The authors state that danazol inhibits microsomal and mitochondrial cytochrome P-450 in cultured adrenal tissue. In fact, the experiments cited were done on isolated mitochondrial and microsomal fractions in vitro
BARBIERI RL. Danazol. Ann Intern Med. ;97:286. doi: 10.7326/0003-4819-97-2-286_1
Download citation file:
Published: Ann Intern Med. 1982;97(2):286.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use